General Announcement::GPL Announces Appointment of Alessandro Riva as CEO of its New Innovation Company

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PH US$200M4.5%210802 - XS1456577334 - 4N4B
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
06-Mar-2019 11:59:03
Status
New
Announcement Sub Title
GPL Announces Appointment of Alessandro Riva as CEO of its New Innovation Company
Announcement Reference
SG190306OTHRZ77C
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Limited
Designation
Company Secretary & Compliance Officer
Effective Date and Time of the event
06/03/2019 09:27:00
Description (Please provide a detailed description of the event in the box below)
Glenmark Pharmaceuticals Announces Appointment of Alessandro Riva as CEO of its New Innovation Company

Attachments

PR_SGX_06032019.pdf
Total size =225K